MSD
Contact UsWorldwide
HomeProductsResearchAbout MSDCorporate Social ResponsibilityCareersLicensingSupply
 

Products Available in the UK
World Leading Portfolio

Our product portfolio covers a range of key therapy areas including atherosclerosis and cardiovascular, diabetes and obesity, infectious diseases, neuroscience and ophthalmology, respiratory, bone, arthritis and analgesia, and vaccines.

Brand name

Generic name

Therapy area

 

ALDOMET®

methyldopa

High Blood Pressure

 

ARCOXIA®▼

etoricoxib

Osteoarthritis, Rheumatoid Arthritis & Gout

Display medicines guide

CANCIDAS®

caspofungin

Fungal infection

Display medicines guide

CLINORIL®

sulindac

Osteoarthritis, Rheumatoid Arthritis & Gout

 

COSOPT®

dorzolamide plus timolol maleate

Ophthalmology

 

COZAAR®

losartan

High Blood Pressure

Display medicines guide

COZAAR-Comp®

losartan plus hydrochlorothiazide

High Blood Pressure

 

CRIXIVAN®

indinavir

HIV & AIDS

 

EMEND®▼

aprepitant

Oncology

Display medicines guide

EZETROL®▼
(MSD and Schering-Plough)

ezetimibe

High Cholesterol

Display medicines guide

FOSAMAX®

sodium alendronate

Osteoporosis

 

FOSAVANCE®▼

sodium alendronate plus cholecalciferol

Osteoporosis

 

INEGY®▼
(MSD and Schering-Plough)

ezetimibe plus simvastatin

High Cholesterol

Display medicines guide

INNOVACE®

enalapril maleate

High Blood Pressure

 

INNOZIDE®

enalapril maleate plus hydrochlorothiazide

High Blood Pressure

 

INVANZ®

ertapenem

Infection

 

ISENTRESS®▼

raltegravir

HIV & AIDS

 

IVEMEND®▼

fosaprepitant

Oncology

 

JANUVIA®▼

sitagliptin

Type 2 Diabetes

Display 



































medicines guide

MAXALT®

rizatriptan

Migraine

Display medicines 



































guide

PEPCID®

famotidine

Ulceration and oesophagitis

 

PERIACTIN®

cyproheptadine hydrochloride

Allergy Relief

 

PRIMAXIN®

imipenum plus cilastatin

Infection

Display medicines guide

PROPECIA®

finasteride

Hair loss

Display medicines guide

PROSCAR®

finasteride

Benign Prostatic Hyperplasia

 

SINGULAIR®

montelukast

Asthma

Display medicines guide

TIMOPTOL®

timolol maleate

Ophthalmology

 

TRUSOPT®

dorzolamide

Ophthalmology

 

UTINOR®

norfloxacin

Infection

 

ZOCOR®

simvastatin

High Cholesterol

Display medicines guide


 
RESEARCH

It costs about £550 million and around 10-12 years to bring one medicine from discovery in a laboratory to the patient.
>>Read more about MSD's research in the UK
 

This site is intended for residents of the United Kingdom. Merck Sharp & Dohme Limited, registered in England No 820771

Privacy Policy Terms of Use Copyright © 1995-2008 Merck Sharp & Dohme Ltd Merck & CO., (USA)